Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
SBT6290
i
Other names:
SBT6290, SBT 6290
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
ARS Pharma
Drug class:
Nectin-4-targeted antibody-drug conjugate, TLR8 agonist
Related drugs:
‹
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SHR-A2102 (1)
BAT8007 (0)
Nectin-4 ADC (0)
SKB410 (0)
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
BDC-2034 (1)
VTX 2337 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
enfortumab vedotin-ejfv (14)
9MW2821 (1)
SHR-A2102 (1)
BAT8007 (0)
Nectin-4 ADC (0)
SKB410 (0)
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
BDC-2034 (1)
VTX 2337 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NECTIN4 expression
Solid Tumor
NECTIN4 expression
Solid Tumor
SBT6290
Sensitive: C2 – Inclusion Criteria
SBT6290
Sensitive
:
C2
SBT6290
Sensitive: C2 – Inclusion Criteria
SBT6290
Sensitive
:
C2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login